Skip to main content
TipRanks
Go Ultimate75% OFF

Marsh & McLennan Companies (MRSH) AI Stock Analysis

0 Followers
CH:MRSH

Marsh & McLennan Companies

(BX Swiss:MRSH)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Diversified, fee-based business modelMMC combines insurance and reinsurance brokerage with consulting, benefits, and administration services, creating diversified revenue sources. The fee-based model and recurring contract-driven elements can support resilient cash generation while client demand for risk and workforce expertise remains durable.
Negative Factors
Elevated and rising leverageHigher leverage reduces financial flexibility if operating performance weakens or financing costs rise. MMC’s substantial debt balance can also compete with acquisitions, shareholder returns, and investment spending for capital, making balance-sheet management an ongoing constraint over the coming quarters.

Marsh & McLennan Companies Business Overview & Revenue Model

Company Description

Marsh & McLennan Companies, Inc. (MRSH) functions as a leading professional services organization, delivering expert guidance and innovative solutions to clients across the vital domains of risk management, strategic planning, and human capital. Base...

Marsh & McLennan Companies Earnings Call Summary

Earnings Call Date:Oct 15, 2026(Q3-2026)|Next Earnings Date:Jan 28, 2027
Earnings Call SentimentPositive

The call was predominantly positive. The company reported strong revenue, operating income, EPS, consulting, risk, and asset-management growth; increased its Thrive savings target; completed its brand transition; highlighted expanding AI and digital-infrastructure opportunities; and maintained its full-year outlook. These strengths were partly offset by soft insurance and reinsurance pricing, a 6% decline in reinsurance revenue, a 1% decline in Workforce and Reward, lower fiduciary interest income, Thrive-related costs, and a litigation charge.

Positive Updates

Strong Third-Quarter Financial Performance
Consolidated revenue increased 8% to $6.9 billion, or 5% on an underlying basis. Adjusted operating income grew 6% to $1.5 billion, adjusted operating margin was 22.7%, and adjusted EPS increased 10% year over year. The CEO stated adjusted EPS was $2.03, while the CFO reported adjusted EPS of $2.3.

Negative Updates

Soft Global Commercial Insurance Pricing
The Mark index declined 5% in the third quarter following a 6% decline in the second quarter. Rates decreased 1% in the U.S., declined mid single digits in Canada, Europe, and Asia, decreased in the high single digits in the U.K. and Latin America, and posted double-digit decreases in the Pacific region.

Company Guidance

Management continues to expect underlying revenue growth in 2026 “similar to last year” and “similar to the levels we generated in 2025,” along with “another year of margin expansion and solid adjusted EPS growth”; management consulting is “on pace for high single digit growth” for the full year, implying a “roughly flat top line in Q4,” while fourth-quarter fiduciary interest income is expected to be “approximately $94 million,” FX to have an “immaterial effect on earnings,” adjusted corporate expense to be “approximately $80 million,” interest expense to be $255 million, and the adjusted effective tax rate to be “around 25% for 2026”; Thrive is expected to generate $600 million in savings, with the “vast majority” of actions taken by the end of 2028, savings realized “fairly evenly over the 3 years of the program,” and approximately $750 million of associated costs; the company continues to expect to deploy approximately $5.5 billion of capital in 2026 across dividends, acquisitions and share repurchases, with the ultimate level of share repurchase dependent on how the M&A pipeline develops, and expects current reinsurance market conditions to persist through the January 1 renewal cycle.

Marsh & McLennan Companies Risk Analysis

Marsh & McLennan Companies disclosed 35 risk factors in its most recent earnings report. Marsh & McLennan Companies reported the most risks in the "Finance & Corporate" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

0 New Risks

Marsh & McLennan Companies Peers Comparison

Overall Rating

UnderperformOutperform
Sector (68)

Financial Indicators

CH:MRSH against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
AJGAJG81Outperform$72.47B42.667.16%0.98%25.60%3.46%
AONAON76Outperform$71.36B18.3340.38%0.95%3.29%46.05%
WTWWTW73Outperform$30.70B20.3019.92%1.14%4.75%-22.03%
BROBRO71Outperform$23.85B19.509.69%0.95%26.10%8.89%
Sector *68Neutral$18.00B11.429.92%3.81%9.73%1.22%
CRD.ACRD.A50Neutral$559.81M22.1314.48%2.55%-3.62%-17.84%

* Financial Sector Average

Performance Comparison

-20%0%20%AONAJGBROCRD.AWTWDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
CH:MRSH and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
AONAon Plc336.55-11.04-3.18%
AJGArthur J. Gallagher282.0128.2911.15%
BROBrown & Brown71.39-7.87-9.93%
CRD.ACrawford & Company A11.950.988.92%
WTWWillis Towers Watson Public Limited Company334.1814.084.40%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.